心臟假體設備市場規模、佔有率、成長分析（按產品類型、按材料類型、按最終用途、按地區）- 產業預測，2025 年至 2032 年

預計 2023 年全球心臟假體設備市場價值將達到 69.3 億美元，並從 2024 年的 74.7 億美元成長到 2032 年的 136.2 億美元，預測期內（2025-2032 年）的複合年成長率為 7.8%。

全球心臟假體市場受到老齡人口快速成長的顯著影響。由於與老齡化的心臟變化，老年人口罹患心血管疾病的風險更高。這種人口結構變化導致主動脈瓣狹窄和心臟衰竭等疾病的發生率上升，促使使用人工瓣膜和心律調節器的外科手術數量激增。同時，微創經導管主動脈瓣置換術(TAVR)、3D 列印個人化心臟瓣膜以及生物相容性材料等技術進步正在提高這些設備的有效性和安全性。這些技術創新不僅降低了手術風險和恢復時間，還改善了長期療效，從而增加了整個醫療領域對人工心臟的需求，並推動了市場的持續成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 重大投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術分析

心臟假體設備市場規模（依產品類型及複合年成長率）（2025-2032）

• 市場概覽
• 心臟瓣膜
  • 人工心臟瓣膜
  • 組織心臟瓣膜
  • 經導管心臟瓣膜 (TAVR)
• 心律調節器
  • 植入式心律調節器
  • 體外心律調節器
• 其他
  • 心室輔助裝置（VAD）
  • 全人工心臟（TAH）

心臟假體設備市場規模（依材料類型及複合年成長率）（2025-2032 年）

• 市場概覽
• 生物材料
  • 牛
  • 豬組織
• 合成材料
  • 鈦
  • 聚氨酯
  • 碳
• 混合材料

心臟假體設備市場規模（依最終用途及複合年成長率） （2025-2032）

• 市場概覽
• 醫院
• 心臟中心診所
• 門診手術中心
• 其他

心臟假體裝置市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• Abbott Laboratories（USA）
• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Edwards Lifesciences Corporation（USA）
• LivaNova PLC（UK）
• Biotronik（Germany）
• MicroPort Scientific Corporation（China）
• Meril Life Sciences Pvt. Ltd.（India）
• Lepu Medical Technology Co., Ltd.（China）
• CryoLife, Inc.（USA）
• AtriCure, Inc.（USA）
• Braile Biomedica（Brazil）
• Labcor Laboratorios Ltda.（Brazil）
• Lifetech Scientific Corporation（China）
• Shree Pacetronix Ltd.（India）
• TTK Healthcare Ltd.（India）
• Colibri Heart Valve LLC（USA）
• Berlin Heart GmbH（Germany）
• SynCardia Systems LLC（USA）
• Venus Medtech（Hangzhou）Inc.（China）

結論和建議

Global Cardiac Prosthetic Devices Market size was valued at USD 6.93 billion in 2023 and is poised to grow from USD 7.47 billion in 2024 to USD 13.62 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The global market for cardiac prosthetic devices is significantly influenced by the rapidly growing elderly population, which faces heightened risks of cardiovascular diseases due to age-related changes in the heart. This demographic shift is resulting in increased incidences of conditions like aortic stenosis and heart failure, leading to a surge in surgical procedures that utilize prosthetic valves and pacemakers. In parallel, technological advancements such as minimally invasive transcatheter aortic valve replacement (TAVR), 3D-printed personalized heart valves, and biocompatible materials are enhancing the efficacy and safety of these devices. These innovations not only decrease surgical risks and recovery times but also improve long-term outcomes, thereby elevating the demand for cardiac prosthetics across healthcare settings and fostering continued market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Prosthetic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Prosthetic Devices Market Segments Analysis

Global Cardiac Prosthetic Devices Market is segmented by Product Type, Material Type, End-Use and region. Based on Product Type, the market is segmented into Heart Valves, Pacemakers and Others. Based on Material Type, the market is segmented into Biological Materials, Synthetic Materials and Hybrid Materials. Based on End-Use, the market is segmented into Hospitals, Cardiac Centers and Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Prosthetic Devices Market

The increasing prevalence of cardiac diseases worldwide is a significant factor propelling the growth of the global cardiac prosthetic devices market. As conditions such as coronary artery disease and heart valve disorders become more common, the demand for prosthetic solutions, including heart valves and vascular grafts, escalates. This rising need not only highlights the urgency for effective treatment options but also paves the way for advancements and innovations within the market. Consequently, this trend creates substantial opportunities for manufacturers and healthcare providers to develop and deliver advanced cardiac prosthetic devices, thereby enhancing patient outcomes and market expansion.

Restraints in the Global Cardiac Prosthetic Devices Market

The Global Cardiac Prosthetic Devices market faces significant challenges due to lengthy and complex regulatory approval processes. The rigorous regulatory demands, along with the necessity for extensive clinical trials and testing, can significantly delay the market entry of new devices. This prolonged timeline not only stifles innovation but also limits patient access to the latest technological advancements. Consequently, these regulatory hurdles can impede progress in the industry, making it difficult for patients to benefit from newly developed cardiac prosthetic solutions in a timely manner.

Market Trends of the Global Cardiac Prosthetic Devices Market

The global cardiac prosthetic devices market is increasingly trending towards advancements in minimally invasive procedures, reflecting a growing preference for technologies that enhance patient outcomes. Innovative devices such as transcatheter heart valves and catheter-based repair systems are gaining traction, driven by their ability to minimize surgical trauma, reduce recovery times, and lower complication risks. As healthcare providers and patients alike prioritize efficiency and safety, the demand for these sophisticated devices is expected to surge. This shift not only aligns with evolving surgical practices but also fosters competitive growth among manufacturers, leading to ongoing technological advancements within the cardiac prosthetics segment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis

Global Cardiac Prosthetic Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Heart Valves
  • Mechanical Heart Valves
  • Tissue Heart Valves
  • Transcatheter Heart Valves (TAVR)
• Pacemakers
  • Implantable Pacemakers
  • External Pacemakers
• Others
  • Ventricular Assist Devices (VADs)
  • Total Artificial Hearts (TAH)

Global Cardiac Prosthetic Devices Market Size by Material Type & CAGR (2025-2032)

• Market Overview
• Biological Materials
  • Bovine Pericardium
  • Porcine Tissue
• Synthetic Materials
  • Titanium
  • Polyurethane
  • Carbon
• Hybrid Materials

Global Cardiac Prosthetic Devices Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Cardiac Centers and Clinics
• Ambulatory Surgical Centers
• Others

Global Cardiac Prosthetic Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Material Type, End-Use)
  • US
  • Canada
• Europe (Product Type, Material Type, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material Type, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material Type, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material Type, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcor Laboratorios Ltda. (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifetech Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shree Pacetronix Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SynCardia Systems LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (Hangzhou) Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations